Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CRVS - Corvus Pharmaceuticals, Inc.
7.86 M
LAST VALUE
-64.45%
2 YEAR CAGR
-34.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR